No Data
Express News | Harrow Inc - Klarity-C Patients to Access Vevye for $59 per Bottle
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $65
Harrow Is Maintained at Buy by B. Riley Securities
Harrow Price Target Cut to $65.00/Share From $69.00 by B. Riley Securities
H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $57
Express News | HC Wainwright & Co. Reiterates Buy on Harrow, Maintains $57 Price Target
Sundancer28 : WOW!! Truly perfection! Good for you
🩷